• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传突变患病率的荟萃分析的统计方法。

Statistical approaches for meta-analysis of genetic mutation prevalence.

机构信息

Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Division of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

出版信息

Genet Epidemiol. 2021 Mar;45(2):154-170. doi: 10.1002/gepi.22364. Epub 2020 Sep 30.

DOI:10.1002/gepi.22364
PMID:33000511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10391692/
Abstract

Estimating the prevalence of rare germline genetic mutations in the general population is of interest as it can inform genetic counseling and risk management. Most studies that estimate the prevalence of mutations are performed in high-risk populations, and each study is designed with differing inclusion criteria, resulting in ascertained populations. Quantifying the effects of ascertainment is necessary to estimate the prevalence in the general population. This quantification is difficult as the inclusion criteria is often based on disease status and/or family history. Combining estimates from multiple studies through a meta-analysis is challenging due to the variety of study designs and ascertainment mechanisms as well as the complexity of quantifying the effect of these mechanisms. We provide guidelines on how to quantify the ascertainment mechanism for a wide range of settings and propose a general approach for conducting a meta-analysis in these complex settings by incorporating study-specific ascertainment mechanisms into a joint likelihood function. We implement the proposed likelihood-based approach using both frequentist and Bayesian methodologies. We evaluate these approaches in simulations and show that the methods are robust and produce unbiased estimates of the prevalence. An advantage of the Bayesian approach is that it can easily incorporate uncertainty in ascertainment probability values. We apply our methods to estimate the prevalence of PALB2 mutations in the United States by combining data from multiple studies and obtain a prevalence estimate of around 0.02%.

摘要

评估常见基因突变的罕见种系在一般人群中的流行率是很有意义的,因为它可以为遗传咨询和风险管理提供信息。大多数评估突变流行率的研究都是在高危人群中进行的,而且每项研究的设计都有不同的纳入标准,导致确定了研究人群。为了估计一般人群中的流行率,量化确定法的效果是必要的。由于纳入标准通常基于疾病状态和/或家族史,因此很难进行这种量化。通过荟萃分析综合多个研究的估计值是具有挑战性的,因为研究设计和确定机制多种多样,以及量化这些机制的影响的复杂性。我们提供了针对广泛情况量化确定机制的指南,并提出了一种在这些复杂情况下进行荟萃分析的一般方法,即将研究特定的确定机制纳入联合似然函数中。我们使用频率主义和贝叶斯方法实现了所提出的基于似然的方法。我们在模拟中评估这些方法,表明这些方法是稳健的,并产生了流行率的无偏估计。贝叶斯方法的一个优点是它可以轻松地将确定概率值的不确定性纳入其中。我们通过合并多个研究的数据来估计美国 PALB2 突变的流行率,并获得了约 0.02%的流行率估计值。

相似文献

1
Statistical approaches for meta-analysis of genetic mutation prevalence.遗传突变患病率的荟萃分析的统计方法。
Genet Epidemiol. 2021 Mar;45(2):154-170. doi: 10.1002/gepi.22364. Epub 2020 Sep 30.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Ascertainment-adjusted maximum likelihood estimation for the additive genetic gamma frailty model.加性遗传伽马脆弱模型的确定性调整最大似然估计。
Lifetime Data Anal. 2004 Sep;10(3):229-45. doi: 10.1023/b:lida.0000036390.15378.5e.
4
Full likelihood analysis of genetic risk with variable age at onset disease--combining population-based registry data and demographic information.全似然分析遗传风险与可变发病年龄疾病-结合基于人群的登记数据和人口统计学信息。
PLoS One. 2009 Aug 31;4(8):e6836. doi: 10.1371/journal.pone.0006836.
5
Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset.当确诊取决于基因型和发病年龄时,利用回顾性似然法从家系数据估计外显率。
Genet Epidemiol. 2004 Sep;27(2):109-17. doi: 10.1002/gepi.20007.
6
Bayesian modelling of imperfect ascertainment methods in cancer studies.癌症研究中不完美确诊方法的贝叶斯建模。
Stat Med. 2005 Aug 15;24(15):2365-79. doi: 10.1002/sim.2116.
7
Maximum likelihood and Bayesian methods for estimating the distribution of selective effects among classes of mutations using DNA polymorphism data.利用DNA多态性数据估计各类突变间选择效应分布的最大似然法和贝叶斯方法。
Theor Popul Biol. 2003 Mar;63(2):91-103. doi: 10.1016/s0040-5809(02)00050-3.
8
PEL: an unbiased method for estimating age-dependent genetic disease risk from pedigree data unselected for family history.PEL:一种用于从未因家族病史而筛选的家系数据中估计年龄依赖性遗传疾病风险的无偏方法。
Genet Epidemiol. 2009 Jul;33(5):379-85. doi: 10.1002/gepi.20390.
9
Estimating disease risk associated with mutated genes in family-based designs.在基于家系的研究设计中评估与突变基因相关的疾病风险。
Hum Hered. 2008;66(4):238-51. doi: 10.1159/000143406. Epub 2008 Jul 9.
10
Univariate and bivariate likelihood-based meta-analysis methods performed comparably when marginal sensitivity and specificity were the targets of inference.当边缘敏感性和特异性是推断目标时,单变量和双变量似然比荟萃分析方法的性能相当。
J Clin Epidemiol. 2017 Mar;83:8-17. doi: 10.1016/j.jclinepi.2016.12.003. Epub 2017 Jan 4.

引用本文的文献

1
Multifactorial Rare Diseases: Can Uncertainty Analysis Bring Added Value to the Search for Risk Factors and Etiopathogenesis?多因素罕见病:不确定性分析能否为危险因素和病因研究带来附加价值?
Medicina (Kaunas). 2021 Jan 28;57(2):119. doi: 10.3390/medicina57020119.

本文引用的文献

1
Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study.在英国生物库研究的 337,205 个人中,蛋白质截断变异的医学相关性。
Nat Commun. 2018 Apr 24;9(1):1612. doi: 10.1038/s41467-018-03910-9.
2
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.在常规诊断环境中对 5589 名 BRCA1/2 阴性乳腺癌指数患者进行基因面板检测:德国遗传性乳腺癌和卵巢癌联合会的研究结果。
Cancer Med. 2018 Apr;7(4):1349-1358. doi: 10.1002/cam4.1376. Epub 2018 Mar 9.
3
Review and Comparison of Electronic Patient-Facing Family Health History Tools.面向患者的电子家庭健康史工具的综述与比较
J Genet Couns. 2018 Apr;27(2):381-391. doi: 10.1007/s10897-018-0235-7. Epub 2018 Mar 6.
4
A Clinical Decision Support Tool to Predict Cancer Risk for Commonly Tested Cancer-Related Germline Mutations.一种用于预测常见检测的癌症相关种系突变癌症风险的临床决策支持工具。
J Genet Couns. 2018 Sep;27(5):1187-1199. doi: 10.1007/s10897-018-0238-4. Epub 2018 Mar 2.
5
Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.明显散发型胰腺腺癌患者中的有害生殖系突变
J Clin Oncol. 2017 Oct 20;35(30):3382-3390. doi: 10.1200/JCO.2017.72.3502. Epub 2017 Aug 2.
6
Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.有阳性家族史的胰腺癌患者中癌症基因种系突变的流行率。
Genet Med. 2018 Jan;20(1):119-127. doi: 10.1038/gim.2017.85. Epub 2017 Jul 20.
7
Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53.巴勒斯坦女性遗传性乳腺癌的基因组分析:遗传异质性与TP53基因的一个始祖突变
Int J Cancer. 2017 Aug 15;141(4):750-756. doi: 10.1002/ijc.30771. Epub 2017 May 19.
8
Beta-binomial model for meta-analysis of odds ratios.用于优势比荟萃分析的贝塔二项式模型。
Stat Med. 2017 May 20;36(11):1715-1734. doi: 10.1002/sim.7233. Epub 2017 Jan 25.
9
A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes.一项对超过35000名乳腺癌女性进行的研究,采用了一个包含25个遗传性癌症基因的基因检测面板进行检测。
Cancer. 2017 May 15;123(10):1721-1730. doi: 10.1002/cncr.30498. Epub 2017 Jan 13.
10
Analysis of protein-coding genetic variation in 60,706 humans.对60706名人类的蛋白质编码基因变异进行分析。
Nature. 2016 Aug 18;536(7616):285-91. doi: 10.1038/nature19057.